Market Cap 5.11M
Revenue (ttm) 58.30M
Net Income (ttm) -33.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -57.72%
Debt to Equity Ratio -0.36
Volume 50,501
Avg Vol 65,078
Day's Range N/A - N/A
Shares Out 1.03M
Stochastic %K 18%
Beta 1.64
Analysts Strong Buy
Price Target $143.88

Company Profile

DNA X, Inc. provides cryptocurrency trading services worldwide. The company operates a cryptocurrency trading platform that allows users to trade and swap cryptocurrencies for other cryptocurrencies or cash-equivalent currencies. It markets its services through word of mouth and earned media on social media platforms. The company serves individual cryptocurrency traders. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. wa...

Industry: Capital Markets
Sector: Financial Services
Phone: 650 378 8100
Fax: 650 378 8109
Address:
4445 Eastgate Mall, Suite 200, San Diego, United States
givesomewater
givesomewater Sep. 11 at 8:49 AM
$SONM Where did that guy go who said there’d be an announcement within two weeks? Was he just lying? 😂
1 · Reply
Bigdubs
Bigdubs Sep. 10 at 5:37 AM
$SONM did some buying on Wednesday… We gotta be close with Scott walker changing his Bio to GPU market place and the mystery person here talking about Platts of GPUs. Love a good shell mystery coming together. Scott was wrong on the two weeks so far but I don’t judge till after a full week late. Officially a 3% holder now, pull up a chair and wait for the volume day.
0 · Reply
givesomewater
givesomewater Sep. 9 at 3:24 PM
$SONM Everyone needs to wake up and reassess what’s happening. It’s becoming increasingly clear that shareholders may be getting played by this CEO.
1 · Reply
danielmaia12
danielmaia12 Sep. 9 at 1:21 PM
$SONM $15M sale of legacy business assets.,.,
0 · Reply
givesomewater
givesomewater Sep. 8 at 7:28 PM
$SONM If we lose $3 support, that’s pretty damn bearish 🥵
0 · Reply
tokenize9387
tokenize9387 Sep. 6 at 6:45 PM
$SONM The Platts of GPUs
5 · Reply
tokenize9387
tokenize9387 Sep. 3 at 11:45 AM
$SONM Compute
1 · Reply
givesomewater
givesomewater Sep. 2 at 6:23 PM
$SONM This is nothing more than prey for short sellers, and the shorts are already trying to drive this company into bankruptcy. It’ll soon fall below $1 and get delisted. Just wait and see.
1 · Reply
tokenize9387
tokenize9387 Sep. 1 at 10:11 AM
$SONM Are you ready
1 · Reply
Bigdubs
Bigdubs Sep. 1 at 2:02 AM
$SONM My biggest risk factor removed! I’m not too worried about the November 18 panel condition, as it pretty much forces management to make sure the Q3 10-Q remains above the stockholders’ equity requirement. This is shaping up for Scott’s timeline of next week just nicely. Question is, what asset is coming??? Well, we know it’s apparently good enough for the board to structure a pretty damn lucrative payday for themselves if the stock jumps 😂 All aboard!!!
0 · Reply
Latest News on SONM
DNA X, Inc. Reports Second Quarter 2026 Financial Results

Aug 19, 2026, 4:15 PM EDT - 24 days ago

DNA X, Inc. Reports Second Quarter 2026 Financial Results


DNA X Quarterly report: Q2 2026

Aug 19, 2026, 7:00 AM EDT - 24 days ago

DNA X Quarterly report: Q2 2026


DNA X Earnings release: Q2 2026

Aug 19, 2026, 7:00 AM EDT - 24 days ago

DNA X Earnings release: Q2 2026


DNA X, Inc. Reports First Quarter 2026 Financial Results

May 20, 2026, 5:00 PM EDT - 3 months ago

DNA X, Inc. Reports First Quarter 2026 Financial Results


DNA X Earnings release: Q1 2026

May 20, 2026, 4:00 PM EDT - 3 months ago

DNA X Earnings release: Q1 2026


DNA X Quarterly report: Q1 2026

May 20, 2026, 4:00 PM EDT - 3 months ago

DNA X Quarterly report: Q1 2026


DNA X Annual report: Q4 2025

Apr 15, 2026, 6:00 AM EDT - 5 months ago

DNA X Annual report: Q4 2025


DNA X Earnings release: Q4 2025

Apr 15, 2026, 6:00 AM EDT - 5 months ago

DNA X Earnings release: Q4 2025


DNA X, Inc. Reports Full Year 2025 Financial Results

Apr 14, 2026, 9:34 PM EDT - 5 months ago

DNA X, Inc. Reports Full Year 2025 Financial Results


DNA X Proxy statement: Proxy Filing

Dec 29, 2025, 7:00 AM EST - 8 months ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Dec 19, 2025, 7:00 AM EST - 8 months ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Dec 5, 2025, 7:00 AM EST - 9 months ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Nov 25, 2025, 7:00 AM EST - 9 months ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Nov 24, 2025, 7:00 AM EST - 9 months ago

DNA X Proxy statement: Proxy Filing


Sonim Technologies Reports Third Quarter 2025 Financial Results

Oct 31, 2025, 8:00 AM EDT - 10 months ago

Sonim Technologies Reports Third Quarter 2025 Financial Results


DNA X Quarterly report: Q3 2025

Oct 31, 2025, 8:00 AM EDT - 10 months ago

DNA X Quarterly report: Q3 2025


DNA X Earnings release: Q3 2025

Oct 31, 2025, 8:00 AM EDT - 10 months ago

DNA X Earnings release: Q3 2025


Sonim Technologies Inc trading halted, news pending

2025-10-24T23:50:35.000Z - 10 months ago

Sonim Technologies Inc trading halted, news pending


DNA X Registration statement: Registration Filing

Oct 9, 2025, 8:00 AM EDT - 11 months ago

DNA X Registration statement: Registration Filing


Sonim files to sell 350M shares of common stock for holders

2025-09-29T21:20:10.000Z - 11 months ago

Sonim files to sell 350M shares of common stock for holders


DNA X Registration statement: Registration Filing

Sep 29, 2025, 8:00 AM EDT - 11 months ago

DNA X Registration statement: Registration Filing


DNA X Proxy statement: Proxy Filing

Sep 19, 2025, 8:00 AM EDT - 11 months ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Sep 9, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Earnings release: Q2 2025

Aug 8, 2025, 7:00 AM EDT - 1 year ago

DNA X Earnings release: Q2 2025


DNA X Quarterly report: Q2 2025

Aug 8, 2025, 7:00 AM EDT - 1 year ago

DNA X Quarterly report: Q2 2025


Sonim XP Pro Ultra-Rugged Smartphone Launches on T-Mobile

Jul 23, 2025, 8:00 AM EDT - 1 year ago

Sonim XP Pro Ultra-Rugged Smartphone Launches on T-Mobile


DNA X Proxy statement: Proxy Filing

Jul 22, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jul 22, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jul 18, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


Sonim Technologies to Be Acquired by Social Mobile

Jul 18, 2025, 7:00 AM EDT - 1 year ago

Sonim Technologies to Be Acquired by Social Mobile


DNA X Proxy statement: Proxy Filing

Jul 14, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jul 11, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


Sonim files to sell 1.65M shares of common stock for holders

2025-07-09T20:10:21.000Z - 1 year ago

Sonim files to sell 1.65M shares of common stock for holders


AJP and Orbic Issue Open Letter to Fellow Sonim Stockholders

Jul 9, 2025, 12:29 PM EDT - 1 year ago

AJP and Orbic Issue Open Letter to Fellow Sonim Stockholders


DNA X Registration statement: Registration Filing

Jul 9, 2025, 8:00 AM EDT - 1 year ago

DNA X Registration statement: Registration Filing


DNA X Proxy statement: Proxy Filing

Jul 9, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jul 7, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jul 2, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 27, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 27, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 26, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 25, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 24, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


Sonim files to sell 6.9M shares of common stock

2025-06-20T21:40:08.000Z - 1 year ago

Sonim files to sell 6.9M shares of common stock


DNA X Registration statement: Registration Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

DNA X Registration statement: Registration Filing


DNA X Proxy statement: Proxy Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 18, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 18, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Jun 16, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


Sonim XP Pro Lands at AT&T Friday, June 6

Jun 4, 2025, 8:30 AM EDT - 1 year ago

Sonim XP Pro Lands at AT&T Friday, June 6


DNA X Proxy statement: Proxy Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

May 23, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Quarterly report: Q1 2025

May 12, 2025, 12:00 AM EDT - 1 year ago

DNA X Quarterly report: Q1 2025


DNA X Earnings release: Q1 2025

May 12, 2025, 12:00 AM EDT - 1 year ago

DNA X Earnings release: Q1 2025


DNA X Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

DNA X Proxy statement: Proxy Filing


Sonim Technologies Reports Full Year 2024 Financial Results

Mar 31, 2025, 4:02 PM EDT - 1 year ago

Sonim Technologies Reports Full Year 2024 Financial Results


DNA X Quarterly report: Q4 2024

Mar 31, 2025, 2:00 PM EDT - 1 year ago

DNA X Quarterly report: Q4 2024


DNA X Earnings release: Q4 2024

Mar 31, 2025, 2:00 PM EDT - 1 year ago

DNA X Earnings release: Q4 2024


DNA X Annual report: Q4 2024

Mar 31, 2025, 2:00 PM EDT - 1 year ago

DNA X Annual report: Q4 2024


DNA X Quarterly report: Q3 2024

Nov 13, 2024, 3:00 PM EST - 1 year ago

DNA X Quarterly report: Q3 2024


DNA X Earnings release: Q3 2024

Nov 13, 2024, 3:00 PM EST - 1 year ago

DNA X Earnings release: Q3 2024


DNA X Registration statement: Registration Filing

Sep 16, 2024, 8:00 AM EDT - 1 year ago

DNA X Registration statement: Registration Filing


DNA X Quarterly report: Q2 2024

Aug 9, 2024, 2:00 PM EDT - 2 years ago

DNA X Quarterly report: Q2 2024


DNA X Earnings release: Q2 2024

Aug 9, 2024, 2:00 PM EDT - 2 years ago

DNA X Earnings release: Q2 2024


DNA X Proxy statement: Proxy Filing

Jun 5, 2024, 8:00 AM EDT - 2 years ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

DNA X Proxy statement: Proxy Filing


DNA X Quarterly report: Q1 2024

May 14, 2024, 2:00 PM EDT - 2 years ago

DNA X Quarterly report: Q1 2024


DNA X Earnings release: Q1 2024

May 14, 2024, 2:00 PM EDT - 2 years ago

DNA X Earnings release: Q1 2024


DNA X Registration statement: Registration Filing

Apr 9, 2024, 8:00 AM EDT - 2 years ago

DNA X Registration statement: Registration Filing


DNA X Quarterly report: Q4 2023

Mar 27, 2024, 3:00 PM EDT - 2 years ago

DNA X Quarterly report: Q4 2023


DNA X Earnings release: Q4 2023

Mar 27, 2024, 3:00 PM EDT - 2 years ago

DNA X Earnings release: Q4 2023


DNA X Annual report: Q4 2023

Mar 27, 2024, 3:00 PM EDT - 2 years ago

DNA X Annual report: Q4 2023


DNA X Registration statement: Registration Filing

Dec 1, 2023, 7:00 AM EST - 2 years ago

DNA X Registration statement: Registration Filing


DNA X Quarterly report: Q3 2023

Nov 14, 2023, 3:00 PM EST - 2 years ago

DNA X Quarterly report: Q3 2023


DNA X Earnings release: Q3 2023

Nov 14, 2023, 3:00 PM EST - 2 years ago

DNA X Earnings release: Q3 2023


DNA X Proxy statement: Proxy Filing

Aug 18, 2023, 8:00 AM EDT - 3 years ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Aug 18, 2023, 8:00 AM EDT - 3 years ago

DNA X Proxy statement: Proxy Filing


DNA X Quarterly report: Q2 2023

Aug 14, 2023, 3:00 PM EDT - 3 years ago

DNA X Quarterly report: Q2 2023


DNA X Earnings release: Q2 2023

Aug 14, 2023, 3:00 PM EDT - 3 years ago

DNA X Earnings release: Q2 2023


DNA X Quarterly report: Q1 2023

May 9, 2023, 2:00 PM EDT - 3 years ago

DNA X Quarterly report: Q1 2023


DNA X Earnings release: Q1 2023

May 9, 2023, 2:00 PM EDT - 3 years ago

DNA X Earnings release: Q1 2023


DNA X Quarterly report: Q4 2022

Mar 20, 2023, 3:00 PM EDT - 3 years ago

DNA X Quarterly report: Q4 2022


DNA X Earnings release: Q4 2022

Mar 20, 2023, 3:00 PM EDT - 3 years ago

DNA X Earnings release: Q4 2022


DNA X Annual report: Q4 2022

Mar 20, 2023, 3:00 PM EDT - 3 years ago

DNA X Annual report: Q4 2022


DNA X Quarterly report: Q3 2022

Nov 14, 2022, 3:00 PM EST - 3 years ago

DNA X Quarterly report: Q3 2022


DNA X Earnings release: Q3 2022

Nov 14, 2022, 3:00 PM EST - 3 years ago

DNA X Earnings release: Q3 2022


DNA X Proxy statement: Proxy Filing

Sep 28, 2022, 8:00 AM EDT - 3 years ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Sep 26, 2022, 8:00 AM EDT - 3 years ago

DNA X Proxy statement: Proxy Filing


DNA X Proxy statement: Proxy Filing

Sep 16, 2022, 8:00 AM EDT - 3 years ago

DNA X Proxy statement: Proxy Filing


DNA X Quarterly report: Q2 2022

Aug 12, 2022, 2:00 PM EDT - 4 years ago

DNA X Quarterly report: Q2 2022


DNA X Earnings release: Q2 2022

Aug 12, 2022, 2:00 PM EDT - 4 years ago

DNA X Earnings release: Q2 2022


Despite Weakness in SONM Stock, These Insiders Look Confident

2022-07-18T14:29:18.000Z - 4 years ago

Despite Weakness in SONM Stock, These Insiders Look Confident


givesomewater
givesomewater Sep. 11 at 8:49 AM
$SONM Where did that guy go who said there’d be an announcement within two weeks? Was he just lying? 😂
1 · Reply
Bigdubs
Bigdubs Sep. 10 at 5:37 AM
$SONM did some buying on Wednesday… We gotta be close with Scott walker changing his Bio to GPU market place and the mystery person here talking about Platts of GPUs. Love a good shell mystery coming together. Scott was wrong on the two weeks so far but I don’t judge till after a full week late. Officially a 3% holder now, pull up a chair and wait for the volume day.
0 · Reply
givesomewater
givesomewater Sep. 9 at 3:24 PM
$SONM Everyone needs to wake up and reassess what’s happening. It’s becoming increasingly clear that shareholders may be getting played by this CEO.
1 · Reply
danielmaia12
danielmaia12 Sep. 9 at 1:21 PM
$SONM $15M sale of legacy business assets.,.,
0 · Reply
givesomewater
givesomewater Sep. 8 at 7:28 PM
$SONM If we lose $3 support, that’s pretty damn bearish 🥵
0 · Reply
tokenize9387
tokenize9387 Sep. 6 at 6:45 PM
$SONM The Platts of GPUs
5 · Reply
tokenize9387
tokenize9387 Sep. 3 at 11:45 AM
$SONM Compute
1 · Reply
givesomewater
givesomewater Sep. 2 at 6:23 PM
$SONM This is nothing more than prey for short sellers, and the shorts are already trying to drive this company into bankruptcy. It’ll soon fall below $1 and get delisted. Just wait and see.
1 · Reply
tokenize9387
tokenize9387 Sep. 1 at 10:11 AM
$SONM Are you ready
1 · Reply
Bigdubs
Bigdubs Sep. 1 at 2:02 AM
$SONM My biggest risk factor removed! I’m not too worried about the November 18 panel condition, as it pretty much forces management to make sure the Q3 10-Q remains above the stockholders’ equity requirement. This is shaping up for Scott’s timeline of next week just nicely. Question is, what asset is coming??? Well, we know it’s apparently good enough for the board to structure a pretty damn lucrative payday for themselves if the stock jumps 😂 All aboard!!!
0 · Reply
focafoca99
focafoca99 Aug. 31 at 9:09 PM
$SONM cleared Nasdaq's $2.5M stockholders' equity requirement but remains under a panel monitor through August 2027.
1 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 7:05 PM
$SONM Very small market cap → large upside if execution succeeds…
1 · Reply
Bigdubs
Bigdubs Aug. 28 at 3:15 PM
$SONM took this screenshot earlier this week after a tip from @TheAlphaCompass Combine it with the latest 8-K and the setup gets pretty wild. I think the board’s compensation structure is scummy as hell, and I’m not trying to defend it. But it also gives them a very direct incentive to get the stock materially higher. It specifically accelerates on a change of control, which is pretty damn interesting given the shell/transition setup here. If they’re going to enrich themselves this way, shareholders are coming along for the ride. ~3% holder actually added yesterday.
0 · Reply
Bigdubs
Bigdubs Aug. 27 at 4:31 PM
$SONM probably the most bullish news I’ve seen in sometime… really is messed up but going into a potential large pivot and giving stock based compensation in this crazy way… yeah I’m juiced.
1 · Reply
focafoca99
focafoca99 Aug. 27 at 11:48 AM
$SONM granted a cash award to its board members in lieu of RSUs.
1 · Reply
TheTarkioTrader
TheTarkioTrader Aug. 22 at 7:35 PM
$ADVB $CVAT $MOVE $PCSA $SONM The underlying deal is real — it’s in CVAT’s SEC filing — but the “10.8¢ locked in, 270% return” framing leaves out some key details. The offer price isn’t fixed: it’s calculated as Net Price ÷ shares outstanding, and that gets recalculated at a record date 45 business days after the tender offer even opens, so the final per-share number can still move. The deal also isn’t done — EGS needs at least 90% of shares tendered, plus a separate $7M side-deal for Alchemy Beverages has to close too. And this plays out over months, not days, with the offer staying open 60+ business days and another 30+ after final pricing is set. The gap between the 3-6¢ trading price and the 10¢+ deal price isn’t free money sitting on the table — it’s the market pricing in real risk that this doesn’t close cleanly. Legit news, just not the guaranteed windfall it’s being sold as.
0 · Reply
LivermoresGhost
LivermoresGhost Aug. 22 at 7:28 PM
$CVAT Cavitation Technologies has execute a buyout for this company at 35 million $. This translate to 10.8c per share, you can finds this on the company SEC filing. The stock right now trades 3.9c, the buyout is for 10.8c. The buyer EGS, has already shown proof of funds, the Definitive Purchase Agreement has already been sign, and on Monday they will file the Tender Offer for submit your shares to the company. Buyout sp: 10.8c Current sp: 3.9c 270% Return on Investment, Tender will start Monday!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! https://www.compuserve.com/pf/story/0022/20260817/9811028.htm $MOVE $SONM $ADVB $PCSA
0 · Reply
Bigdubs
Bigdubs Aug. 21 at 3:37 AM
$SONM only thing I got on timing was from the PR not even the 10Q: “The Company expects revenue from the trading platform to begin towards the end of the third quarter 2026 or the beginning of the fourth quarter 2026.” Something needs to meaningfully change to receive revenue. Hopefully that meaningfully change brings home the bacon 🥓.
0 · Reply
UnholyNoodle
UnholyNoodle Aug. 18 at 4:53 PM
$SONM bored to death by this waiting but they didnt pump 5M into this shell just to let it go to waste
0 · Reply
tokenize9387
tokenize9387 Aug. 12 at 8:20 AM
$SONM whispers
0 · Reply
Bigdubs
Bigdubs Aug. 11 at 7:03 PM
$SONM Couple of things soon. The remaining preferred shares being sold to DNA X ( Scott Walker and co) and the 10Q is due soon. Could another catalyst be included maybe but not guaranteed.  I hate to time predict with shells as normally you’re always wrong but there are a few events over the next week to keep eyes on.
0 · Reply